KIT and leukemia: As shown in present studies, the use of pure population of induced lin−CD34+CD90+CD117+-CD45+CD38+/− BCR-ABL+ cells enabled identification of genes affected by imatinib treatment and eventually led to discovery of novel survival factor for primitive leukemia cells OLFM4.